Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2023 | Jul. 31, 2023 | |
Document and Entity Information | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Transition Report | false | |
Entity File Number | 001-39961 | |
Entity Registrant Name | BLUERIVER ACQUISITION CORP. | |
Entity Incorporation, State or Country Code | E9 | |
Entity Tax Identification Number | 98-1577027 | |
Entity Address, Address Line One | 250 West Nottingham Drive | |
Entity Address, Address Line Two | Suite 400 | |
Entity Address, City or Town | San Antonio | |
Entity Address State Or Province | TX | |
Entity Address, Postal Zip Code | 78209 | |
City Area Code | 210 | |
Local Phone Number | 832-3305 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Entity Central Index Key | 0001831006 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false | |
Class A ordinary shares | ||
Document and Entity Information | ||
Title of 12(b) Security | Class A ordinary shares included as part of the units | |
Trading Symbol | BLUA | |
Security Exchange Name | NYSEAMER | |
Entity Common Stock, Shares Outstanding | 2,811,745 | |
Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | ||
Document and Entity Information | ||
Title of 12(b) Security | Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | |
Trading Symbol | BLUA WS | |
Security Exchange Name | NYSEAMER | |
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant | ||
Document and Entity Information | ||
Title of 12(b) Security | Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant | |
Trading Symbol | BLUA.U | |
Security Exchange Name | NYSEAMER | |
Class B ordinary shares | ||
Document and Entity Information | ||
Entity Common Stock, Shares Outstanding | 7,187,500 |
CONDENSED BALANCE SHEETS
CONDENSED BALANCE SHEETS - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash | $ 105,784 | $ 21,548 |
Prepaid expenses | 42,500 | 19,605 |
Total current assets | 148,284 | 41,153 |
Cash and investments held in Trust Account | 21,171,880 | 291,525,100 |
Total Assets | 21,320,164 | 291,566,253 |
Current liabilities: | ||
Accounts payable | 860,699 | 555,911 |
Accrued expenses | 885,000 | 602,021 |
Working capital loan - related party | 645,000 | 100,800 |
Total current liabilities | 2,390,699 | 1,258,732 |
Deferred legal fees | 176,982 | 176,982 |
Deferred underwriting commissions | 10,062,500 | 10,062,500 |
Derivative warrant liabilities | 295,500 | 197,000 |
Total liabilities | 12,925,681 | 11,695,214 |
Commitments and Contingencies | ||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 2,011,744 and 28,750,000 shares issued and outstanding at approximately $10.47 and $10.14 per share as of June 30, 2023 and December 31, 2022, respectively | 21,071,880 | 291,425,100 |
Shareholders' Deficit: | ||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||
Additional paid-in capital | 115,508 | |
Accumulated deficit | (12,793,704) | (11,554,860) |
Total shareholders' deficit | (12,677,397) | (11,554,061) |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | 21,320,164 | 291,566,253 |
Class A Common Stock Not Subject to Possible Redemption | ||
Shareholders' Deficit: | ||
Common stock | 80 | 80 |
Class B ordinary shares | ||
Shareholders' Deficit: | ||
Common stock | $ 719 | $ 719 |
CONDENSED BALANCE SHEETS (Paren
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares | Jun. 30, 2023 | Dec. 31, 2022 |
Class A ordinary shares subject to possible redemption, shares outstanding | 2,011,744 | |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
preference shares, shares authorized | 1,000,000 | 1,000,000 |
preference shares, shares issued | 0 | 0 |
preference shares, shares outstanding | 0 | 0 |
Class A ordinary shares | ||
Ordinary shares, par value (per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, shares outstanding | 2,811,744 | 29,550,000 |
Class A ordinary shares subject to possible redemption | ||
Class A ordinary shares subject to possible redemption, par value | $ 0.0001 | $ 0.0001 |
Class A ordinary shares subject to possible redemption, shares issued | 2,011,744 | 28,750,000 |
Class A ordinary shares subject to possible redemption, shares outstanding | 2,011,744 | 28,750,000 |
Purchase price, per unit | $ 10.47 | $ 10.14 |
Class A Common Stock Not Subject to Possible Redemption | ||
Common shares, shares issued | 800,000 | 800,000 |
Ordinary shares, shares outstanding | 800,000 | 800,000 |
Class B ordinary shares | ||
Ordinary shares, par value (per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares authorized | 20,000,000 | 20,000,000 |
Common shares, shares issued | 7,187,500 | 7,187,500 |
Ordinary shares, shares outstanding | 7,187,500 | 7,187,500 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
General and administrative expenses | $ 332,966 | $ 117,402 | $ 2,427,080 | $ 350,073 |
General and administrative expenses - related party | 150,000 | 166,121 | 300,000 | 316,121 |
Loss from operations | (482,966) | (283,523) | (2,727,080) | (666,194) |
Other income (loss): | ||||
Income from cash and investments held in Trust Account | 179,734 | 130,279 | 1,585,936 | 137,369 |
Change in fair value of derivative warrant liabilities | 73,875 | 1,379,000 | (98,500) | 4,826,500 |
Change in fair value of working capital loan - related party | 5,340 | 0 | 800 | 0 |
Total other income (loss) | 258,949 | 1,509,279 | 1,488,236 | 4,963,869 |
Net (loss) income | $ (224,017) | $ 1,225,756 | $ (1,238,844) | $ 4,297,675 |
Class A ordinary shares | ||||
Other income (loss): | ||||
Weighted average shares outstanding, basic | 2,811,745 | 29,550,000 | 7,119,575 | 29,550,000 |
Weighted average shares outstanding, diluted | 2,811,745 | 29,550,000 | 7,119,575 | 29,550,000 |
Basic net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
Diluted net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
Class B ordinary shares | ||||
Other income (loss): | ||||
Weighted average shares outstanding, basic | 7,187,500 | 7,187,500 | 7,187,500 | 7,187,500 |
Weighted average shares outstanding, diluted | 7,187,500 | 7,187,500 | 7,187,500 | 7,187,500 |
Basic net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
Diluted net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
CONDENSED STATEMENTS OF CHANGES
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($) | Class A ordinary shares Ordinary Shares | Class B ordinary shares Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at the beginning at Dec. 31, 2021 | $ 80 | $ 719 | $ 0 | $ (16,115,670) | $ (16,114,871) |
Balance at the beginning (in shares) at Dec. 31, 2021 | 800,000 | 7,187,500 | |||
Increase (Decrease) in Stockholders' Equity | |||||
Net loss | $ 0 | $ 0 | 0 | 3,071,919 | 3,071,919 |
Balance at the end at Mar. 31, 2022 | $ 80 | $ 719 | 0 | (13,043,751) | (13,042,952) |
Balance at the end (in shares) at Mar. 31, 2022 | 800,000 | 7,187,500 | |||
Balance at the beginning at Dec. 31, 2021 | $ 80 | $ 719 | 0 | (16,115,670) | (16,114,871) |
Balance at the beginning (in shares) at Dec. 31, 2021 | 800,000 | 7,187,500 | |||
Increase (Decrease) in Stockholders' Equity | |||||
Net loss | 4,297,675 | ||||
Balance at the end at Jun. 30, 2022 | $ 80 | $ 719 | 0 | (11,875,749) | (11,874,950) |
Balance at the end (in shares) at Jun. 30, 2022 | 800,000 | 7,187,500 | |||
Balance at the beginning at Mar. 31, 2022 | $ 80 | $ 719 | 0 | (13,043,751) | (13,042,952) |
Balance at the beginning (in shares) at Mar. 31, 2022 | 800,000 | 7,187,500 | |||
Increase (Decrease) in Stockholders' Equity | |||||
Increase in Class A ordinary shares subject to possible redemption | $ 0 | $ 0 | 0 | (57,754) | (57,754) |
Net loss | 0 | 0 | 0 | 1,225,756 | 1,225,756 |
Balance at the end at Jun. 30, 2022 | $ 80 | $ 719 | 0 | (11,875,749) | (11,874,950) |
Balance at the end (in shares) at Jun. 30, 2022 | 800,000 | 7,187,500 | |||
Balance at the beginning at Dec. 31, 2022 | $ 80 | $ 719 | 0 | (11,554,860) | (11,554,061) |
Balance at the beginning (in shares) at Dec. 31, 2022 | 800,000 | 7,187,500 | |||
Increase (Decrease) in Stockholders' Equity | |||||
Stock compensation expense | $ 0 | $ 0 | 1,701,444 | 0 | 1,701,444 |
Shareholder non-redemption agreement | 0 | 0 | 2,333,639 | 0 | 2,333,639 |
Contribution from the Sponsor | 0 | 0 | (2,333,639) | 0 | (2,333,639) |
Increase in Class A ordinary shares subject to possible redemption | 0 | 0 | (1,406,202) | 0 | (1,406,202) |
Net loss | 0 | 0 | 0 | (1,014,827) | (1,014,827) |
Balance at the end at Mar. 31, 2023 | $ 80 | $ 719 | 295,242 | (12,569,687) | (12,273,646) |
Balance at the end (in shares) at Mar. 31, 2023 | 800,000 | 7,187,500 | |||
Balance at the beginning at Dec. 31, 2022 | $ 80 | $ 719 | 0 | (11,554,860) | (11,554,061) |
Balance at the beginning (in shares) at Dec. 31, 2022 | 800,000 | 7,187,500 | |||
Increase (Decrease) in Stockholders' Equity | |||||
Net loss | (1,238,844) | ||||
Balance at the end at Jun. 30, 2023 | $ 80 | $ 719 | 115,508 | (12,793,704) | (12,677,397) |
Balance at the end (in shares) at Jun. 30, 2023 | 800,000 | 7,187,500 | |||
Balance at the beginning at Mar. 31, 2023 | $ 80 | $ 719 | 295,242 | (12,569,687) | (12,273,646) |
Balance at the beginning (in shares) at Mar. 31, 2023 | 800,000 | 7,187,500 | |||
Increase (Decrease) in Stockholders' Equity | |||||
Increase in Class A ordinary shares subject to possible redemption | $ 0 | $ 0 | (179,734) | 0 | (179,734) |
Net loss | 0 | 0 | 0 | (224,017) | (224,017) |
Balance at the end at Jun. 30, 2023 | $ 80 | $ 719 | $ 115,508 | $ (12,793,704) | $ (12,677,397) |
Balance at the end (in shares) at Jun. 30, 2023 | 800,000 | 7,187,500 |
CONDENSED STATEMENTS OF CASH FL
CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Cash Flows from Operating Activities: | ||||
Net (loss) income | $ (1,238,844) | $ 4,297,675 | ||
Adjustments to reconcile net (loss) income to net cash used in operating activities: | ||||
Income from cash and investments held in Trust Account | $ (179,734) | $ (130,279) | (1,585,936) | (137,369) |
Change in fair value of derivative warrant liabilities | (73,875) | (1,379,000) | 98,500 | (4,826,500) |
Change in fair value of working capital loan - related party | (5,340) | 0 | (800) | 0 |
Stock Compensation Expense | 1,701,444 | |||
Changes in operating assets and liabilities: | ||||
Prepaid expenses | (22,895) | 22,916 | ||
Accounts payable | 304,788 | (32,081) | ||
Accrued expenses | 282,979 | 217,093 | ||
Deferred legal fees | 8,210 | |||
Net cash used in operating activities | (460,764) | (450,056) | ||
Cash Flows from Investing Activities: | ||||
Cash withdrawn from Trust Account in connection with redemption | 271,939,156 | |||
Net cash provided by investing activities | 271,939,156 | |||
Cash Flows from Financing Activities: | ||||
Redemption of Class A ordinary shares | (271,939,156) | |||
Proceeds from issuance of working capital loan to related party | 545,000 | |||
Offering costs paid | (75,000) | |||
Net cash used in financing activities | (271,394,156) | (75,000) | ||
Net change in cash | 84,236 | (525,056) | ||
Cash - beginning of the period | 21,548 | 562,346 | ||
Cash - end of the period | $ 105,784 | $ 37,290 | $ 105,784 | $ 37,290 |
Description of Organization, Bu
Description of Organization, Business Operations and Liquidity | 6 Months Ended |
Jun. 30, 2023 | |
Description of Organization, Business Operations and Liquidity | |
Description of Organization, Business Operations and Liquidity | Note 1 — Description of Organization, Business Operations and Liquidity BlueRiver Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on October 19, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of June 30, 2023, the Company had not commenced any operations. All activity for the period from October 19, 2020 (inception) through June 30, 2023 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”) described below, and subsequent to the Initial Public Offering, searching for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on its investments held in the trust account from the proceeds of its Initial Public Offering. The Company’s sponsor is BlueRiver Ventures, LLC, a Cayman Islands exempted company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on January 28, 2021. On February 2, 2021, the Company consummated its Initial Public Offering of 28,750,000 units (each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 3,750,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $287.5 million, and incurring offering costs of approximately $16.4 million, inclusive of approximately $10.1 million in deferred underwriting commissions (Note 5). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 800,000 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”), at a price of $10.00 per Private Placement Unit with the Sponsor, generating gross proceeds of approximately $8.0 million (Notes 4 and 6). Upon the closing of the Initial Public Offering and the Private Placement, $287.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. However, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), as of May 4, 2023, the Company instructed Continental, the trustee with respect to the Trust Account, to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and moved all funds in the Trust Account in cash until the earlier of consummation of our initial business combination or liquidation to a demand deposit account at Citibank. As a result, following such liquidation, the Company will likely receive minimal interest on the funds held in the Trust Account, which would reduce the dollar amount the Company’s public shareholders would receive upon any redemption or liquidation of the Company. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target business or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders (the “Public Shareholders”) of its Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, subject to applicable law and stock exchange listing requirements. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company will adopt upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination or to not vote at all. Subsequent to the consummation of the Initial Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares, private placement shares (the “Private Placement Shares”) underlying the Private Placement Units and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association that would (a) modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its Business Combination within 36 months (including 6 month extensions approved on January 31, 2023 and August 2, 2023) from the closing of this offering, or February 2, 2024, or during any Extension Period (as such period may be extended by the Company’s shareholders in accordance with the Amended and Restated Memorandum and Articles of Association, the “Combination Period”) or (b) with respect to any other material provision relating to the rights of Public Shareholders, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten The initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account or potentially less. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. On March 9, 2023, the Company announced its intention to transfer the listing of its securities from NYSE to the NYSE American LLC (“NYSE American”). In connection with listing on the NYSE American, the Company will voluntarily delist from the New York Stock Exchange. Following the transfer of its listing, the Company intends to continue to file the same periodic reports and other information it currently files with the Securities and Exchange Commission. The Company completed the listing transfer of its securities to NYSE American on March 21, 2023 and began trading on NYSE American on March 24, 2023. Trust Account Redemptions and Extension of Combination Period On January 25, 2023, the Company and the Sponsor, entered into a non-redemption agreement (“Non-Redemption Agreement”) with one or more unaffiliated third party or parties in exchange for such third party or third parties agreeing not to redeem an aggregate of 200,000 shares of the Company sold in its initial public offering (“Non-Redeemed Shares”) at the special meeting called by the Company (the “Special Meeting”) to approve an extension of time for the Company to consummate an initial business combination (the “Extension Proposal”) from February 2, 2023 to August 2, 2023 (the “Extension”). In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to such third party or third parties an aggregate of 50,000 shares of the Company held by the Sponsor immediately following consummation of an initial business combination if they continue to hold such Non-Redeemed Shares through the Special Meeting. The Non-Redemption Agreements are not expected to increase the likelihood that the Extension Proposal is approved by Company shareholders but will increase the amount of funds that remain in the Company’s trust account following the Special Meeting. On January 31, 2023, the Company held a Special Meeting at which the shareholders voted to extend the time the Company has to consummate an initial business combination from February 2, 2023 to August 2, 2023. In connection with such vote, on January 27, 2023, the holders of an aggregate of 26,738,255 Public Shares exercised their right to redeem their shares for an aggregate of approximately $271,939,156 in cash held in the Trust Account. On July 25, 2023, the Company and the Sponsor, entered into a non-redemption agreement (“Non-Redemption Agreement”) with one or more unaffiliated third party or parties in exchange for such third party or third parties agreeing not to redeem an aggregate of 200,000 shares of the Company sold in its initial public offering (“Non-Redeemed Shares”) at the special meeting called by the Company (the “Second Special Meeting”) to approve an extension of time for the Company to consummate an initial business combination (the “Second Extension Proposal”) from August 2, 2023 to February 2, 2024 (the “Second Extension”). In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to such third party or third parties an aggregate of 50,000 shares of the Company held by the Sponsor immediately following consummation of an initial business combination if they continue to hold such Non-Redeemed Shares through the Second Special Meeting. The Non-Redemption Agreements are not expected to increase the likelihood that the Second Extension Proposal is approved by Company shareholders but will increase the amount of funds that remain in the Company’s trust account following the Second Special Meeting. On August 2, 2023, the Company held the Second Special Meeting at which the shareholders voted to extend the time the Company has to consummate an initial business combination from August 2, 2023 to February 2, 2024. Liquidity and Going Concern As of June 30, 2023, the Company had approximately $106,000 in its operating bank account and a working capital deficit of approximately $2.3 million. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $79,000 from the Sponsor under the Note (as defined in Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on February 5, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On November 9, 2022, the Company entered into a promissory note agreement (“Sponsor Note”) with the Sponsor, providing the Company the ability to borrow up to $1.5 million. On November 17, 2022, the Company drew down $100,000 under the Sponsor Note agreement. At various dates during the six months ended the Company drew down an additional $545,000 under the Sponsor Note agreement. As of June 30, 2023 and December 31, 2022, there was $645,000 and $100,000, respectively, outstanding under the Working Capital Loans. Management has determined that the Company does not have sufficient funds and may need to borrow from its Sponsor to fund the working capital needs of the Company until the consummation of an initial Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity condition, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 2, 2024. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a Business Combination before the mandatory liquidation date. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these unaudited condensed financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. On May 1, 2023, First Republic Bank became insolvent. Federal regulators seized the assets of the bank and negotiated a sale of its assets to JP Morgan Chase. The Company held deposits with this bank. As a result of the sale of the assets to JP Morgan Chase, the Company believes its insured and uninsured deposits are not at risk. |
Basis of Presentation and Summa
Basis of Presentation and Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2023 | |
Basis of Presentation and Summary of Significant Accounting Policies | |
Basis of Presentation and Summary of Significant Accounting Policies | Note 2 — Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X and pursuant to the rules and regulations of the SEC. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they are not required for interim financial statements under U.S. GAAP and the rules of the SEC. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the three and six months ended June 30, 2023, and since inception are not necessarily indicative of the results that may be expected through December 31, 2023, or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on March 31, 2023. Emerging Growth Company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed financial statements in conformity with U. S GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022. Cash and Investments Held in Trust Account The Company classifies its U.S. Treasury and equivalent securities as held to maturity in accordance with FASB Accounting Standard Codification (“ASC”) Topic 320, “Investments – Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts. With respect to the regulation of special purpose acquisition companies (“SPACs”) like the Company, on March 30, 2022, the SEC issued proposed rules relating to, among other items, the circumstances in which SPACs could become subject to regulation under the Investment Company Act. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, in May 2023 the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account until the earlier of consummation of a Business Combination and liquidation of the Company. This may reduce the amount of interest earned by the funds in the Trust Account. As of June 30, 2023, the funds in the Trust Account are held solely in an interest-bearing demand deposit account. At June 30, 2023, substantially all of the assets held in the Trust Account were held in cash. At December 31, 2022, substantially all of the assets held in the Trust Account were held in money market funds which invest primarily in U.S. Treasury securities. The money market funds are presented at fair value within the accompanying condensed balance sheets, and fair value of the investments in the Trust Account is equal to the amortized cost basis of the money market funds. Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year that exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets due to their short-term nature, except for derivative warrant liabilities (see Note 9). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Subtopic 815-15 “Derivatives and Hedging — Embedded Derivatives” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants (as defined in Note 4) (collectively, the “warrants”) are recognized as derivative liabilities in accordance with ASC Subtopic 815-40 “Derivatives and Hedging - Contracts in Entity’s Own Equity” (“ASC 815-40”). Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the Public Warrants and the fair value of the Private Placement Warrants has been estimated using a binomial lattice model in a risk-neutral framework. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. The fair value of the Warrants as of June 30, 2023 and December 31, 2022 is based on observable listed prices for such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Convertible Instruments The Company accounted for the Working Capital Loans, as described in Note 4, analyzing the conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments. The Company reviews the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense. It was determined that the conversion option was de minimis, as such the Company has recorded the Working Capital Loans at par value. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A ordinary shares are charged against their carrying value upon the completion of the Initial Public Offering. For the year ended December 31, 2021, of the total offering costs of the Initial Public Offering, approximately $590,000 is included in offering cost - derivative warrant liabilities in the unaudited condensed statements of operations and approximately $15.8 million is allocated as a reduction to the initial carrying value of the redeemable Class A ordinary shares. The Company will keep deferred underwriting commissions classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. As part of the Private Placement, the Company issued 800,000 shares of Class A ordinary shares to the Sponsor (“Private Placement Shares”). These Private Placement Shares will not be transferable, assignable or salable until 30 days after the completion of the initial business combination, and as such are considered non-redeemable and presented as permanent equity in the Company’s condensed balance sheets. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2023 and December 31, 2022, 2,011,744 and 28,750,000 Class A ordinary shares subject to possible redemption, respectively, are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A ordinary shares resulted in charges against additional paid-in capital and accumulated deficit. Income Taxes The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net (Loss) Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of ordinary shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. This presentation assumes a business combination as the most likely outcome. Net (loss) income per ordinary share is calculated by dividing the net (loss) income by the weighted average ordinary shares outstanding for the respective period. The calculation of diluted net (loss) income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 9,850,000 Class A ordinary shares in the calculation of diluted (loss) income per ordinary share, because their exercise is contingent upon future events. As a result, diluted net (loss) income per ordinary share is the same as basic net (loss) income per share ordinary for the three and six months ended June 30, 2023 and 2022. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. The Company has considered the effect of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares. The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per ordinary share for each class of ordinary shares: For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net (loss) income - Basic and diluted $ (62,993) $ (161,024) $ 985,943 $ 239,813 $ (616,481) $ (622,363) $ 3,456,857 $ 840,818 Denominator: Basic and diluted weighted average ordinary shares outstanding 2,811,745 7,187,500 29,550,000 7,187,500 7,119,575 7,187,500 29,550,000 7,187,500 Basic and diluted net (loss) income per ordinary share $ (0.02) $ (0.02) $ 0.03 $ 0.03 $ (0.09) $ (0.09) $ 0.12 $ 0.12 Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the unaudited condensed financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. |
Initial Public Offering
Initial Public Offering | 6 Months Ended |
Jun. 30, 2023 | |
Initial Public Offering | |
Initial Public Offering | Note 3 — Initial Public Offering On February 2, 2021, the Company consummated its Initial Public Offering of 28,750,000 Units, including 3,750,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $287.5 million, and incurring offering costs of approximately $16.4 million, inclusive of approximately $10.1 million in deferred underwriting commissions. Each Unit consists of one Class A ordinary share, and one-third |
Related Party Transactions
Related Party Transactions | 6 Months Ended |
Jun. 30, 2023 | |
Related Party Transactions | |
Related Party Transactions | Note 4 — Related Party Transactions Founder Shares On October 30, 2020, the Sponsor paid $25,000 to cover certain expenses of the Company in consideration of 7,187,500 Class B ordinary shares, par value $0.0001, (the “Founder Shares”). The Sponsor agreed to forfeit up to 937,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement Shares) after the Initial Public Offering. The underwriters fully exercised the over-allotment option on February 2, 2021; thus, these 937,500 Founder Shares were no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the last reported sale price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Private Placement Units Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 800,000 Private Placement Units, at a price of $10.00 per Private Placement Unit with the Sponsor, generating gross proceeds of approximately $8.0 million. The Private Placement Units (including the Private Placement Shares, the Private Placement Warrants (as defined below) and Class A ordinary shares issuable upon exercise of such warrants) will not be transferable or salable until 30 days after the completion of the initial Business Combination. Each whole Private Placement Warrant underlying the Private Placement Units (the “Private Placement Warrants”) is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Units and the underlying securities will expire worthless. The Private Placement Warrants will be non-redeemable (except as described in Note 6 below under “Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00”) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Units until 30 days after the completion of the initial Business Combination. Related Party Loans On October 23, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and due upon the completion of the Initial Public Offering. The Company had borrowed approximately $79,000 under the Note and on February 5, 2021, the Company fully repaid the Note. Subsequent to the repayment, the facility was no longer available to the Company. In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. On November 9, 2022, the Company entered into a promissory note agreement (“Sponsor Note”) with the Sponsor, providing the Company the ability to borrow up to $1.5 million. On November 17, 2022, the Company drew down $100,000 under the Sponsor Note agreement. The Company drew down $250,000, $75,000, $20,000, $25,000 and $175,000 under the Sponsor Note, on January 31, 2023, February 27, 2023, March 24, 2023, April 25, 2023 and May 9, 2023 respectively. As of June 30, 2023 and December 31, 2022, the Company had borrowings of $645,000 and $100,000, respectively, under the Working Capital Loans. Administrative Support Agreement The Company entered into an agreement pursuant to which, commencing on the effective date of the Company’s prospectus through the earlier of consummation of the initial Business Combination or the Company’s liquidation, the Company agreed to pay an affiliate of the Sponsor for administrative and other related services provided to the Company in the amount of $50,000 per month; provided, however that such amount may be higher or lower depending on actual costs incurred during the month. Administrative expenses were included within general and administrative expenses - related party in the unaudited condensed statements of operations. For the three and six months ended June 30, 2023, the Company incurred $150,000 and $300,000, respectively, in administrative expenses. For the three and six months ended June 30, 2022, the Company incurred $150,000 and $300,000, respectively, in administrative expenses. As of June 30, 2023, the Company had a $785,000 outstanding balance, which has been included in accrued expenses on the condensed balance sheets. As of December 31, 2022, the Company had a $600,000 outstanding balance, which has been included in accrued expenses on the condensed balance sheets. In addition, the Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account. Other than these payments and reimbursements, no compensation of any kind, including finders’ and consulting fees, will be paid by the Company to the Sponsor, executive officers and directors, or any of their respective affiliates, prior to completion of the initial Business Combination. For the three and six months ended June 30, 2023, there was $1,141 incurred for such expenses included in general and administrative expenses in the accompanying statements of operations. For the three and six months ended June 30, 2022, there was $16,121 incurred for such expenses included in general and administrative expenses in the accompanying statements of operations. There was no outstanding balance in the accompanying condensed balance sheets as of June 30, 2023 and December 31, 2022. Non-redemption Agreement On January 25, 2023, the Sponsor entered into Non-Redemption Agreements with various shareholders of the Company pursuant to which these shareholders have committed not to redeem their BLUA shares in connection with the Special Meeting held on January 31, 2023, but still retained their right to redeem in connection with the closing of the Business Combination. The commitment to not redeem was accepted by holders of 1,932,000 shares of Class A ordinary shares. In consideration of this agreement, the Sponsor agreed to transfer a portion of its Class B ordinary shares to the Non-Redeeming Shareholders at the closing of the Business Combination. Each Shareholder committed to maintain at least 9.9% of the identified stock and in return will obtain 50,000 of the identified shares as Class B ordinary shares. The Company estimated the aggregate fair value of the 483,000 founders shares attributable to the Non-Redeeming Shareholders to be $2,333,639 or $4.83 per share. Each Non-Redeeming Shareholder acquired from the Sponsor an indirect economic interest in the founder shares. The excess of the fair value of the founder shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, in substance, it was recognized by the Company as a capital contribution by the Sponsor to induce these holders of the Class A shares not to redeem, with a corresponding charge to additional paid-in capital to recognize the fair value of the shares transferred as an offering cost. The fair value of the founders shares was based on the following significant inputs: January 25, 2023 Share price at grant date $ 10.03 Risk-free interest rate 4.67 % Remaining life of SPAC (assuming the Extended Date) 0.52 Value in no De-SPAC scenario $ 10.39 Probability of transaction 50 % Discount rate 5 % |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies | |
Commitments and Contingencies | Note 5 — Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Units, Private Placement Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Founder Shares and upon conversion of the Working Capital Loans), were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon consummation of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement the Company’s initial shareholders entered into and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the Company’s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 3,750,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised the over-allotment option on February 2, 2021. The underwriters were entitled to an underwriting discount of $0.20 per Unit, or approximately $5.8 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $10.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Consulting Agreement On March 13, 2023, the Company entered into an agreement for advisory services in which the advisor assisted the Company as its financial advisor to meet current exchange listing requirements for NYSE American. In consideration of the Services, the Company shall pay IB CAP a fee of $100,000 and 350,000 founder shares of the Company. The $100,000 will be payable upon signing of the Engagement Letter and the shares will be delivered once evidence is provided that the Services have been completed. The Company agrees that the founder shares to be allocated to IB CAP are not subject to forfeiture and will not be subject to forfeiture in the future. The allocation of the Founder Shares to the advisor is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Company estimated the aggregate fair value of the 350,000 founders shares attributable to the advisor to be $1,701,444 or $4.86 per share. The Founder Shares were granted subject to a performance condition (i.e., the listing on NYSE American). Compensation expense related to the Founder Shares is recognized only when the performance condition is met under the applicable accounting literature in this circumstance. As of June 30, 2023, the performance condition had been met and therefore, $1,701,444 of stock-based compensation expenses has been recognized in the accompanying condensed statement of operations as of June 30, 2023. The fair value of the founders shares was based on the following significant inputs: March 21, 2023 Share price at grant date $ 10.15 Risk-free interest rate 4.62 % Remaining life of SPAC (assuming the Extended Date) 0.37 Share price in no De-SPAC scenario $ 10.39 Probability of transaction 50 % Discount rate 5 % |
Derivative Warrant Liabilities
Derivative Warrant Liabilities | 6 Months Ended |
Jun. 30, 2023 | |
Derivative Warrant Liabilities | |
Derivative Warrant Liabilities | Note 6 — Derivative Warrant Liabilities As of June 30, 2023 and December 31, 2022, the Company had 9,583,333 Public Warrants and 266,667 Private Warrants outstanding. Public Warrants may only be exercised in whole and only for a whole number of shares. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrant has an exercise price of $11.50, subject to adjustments as described herein, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the “Newly Issued Price”, (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of warrants when the price per Class A ordinary share equal or exceed $10.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. The Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination (except pursuant to limited exceptions to the officers and directors and other persons or entities affiliated with the initial purchasers of the Private Placement Warrants) and they will not be redeemable by the Company (except as described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00”) so long as they are held by the Sponsor or its permitted transferees (except as otherwise set forth herein). The Sponsor, or its permitted transferees, has the option to exercise the Private Placement Warrants on a cashless basis. If the private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the Public Warrants. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 . Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption; and ● if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”). The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 . After the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; ● if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and ● if the Reference Value is less than $18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holders’ ability to cashless exercise its warrants) as the outstanding Public Warrants as described above. The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). If the Company has not completed the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. |
Class A Ordinary Shares Subject
Class A Ordinary Shares Subject to Possible Redemption | 6 Months Ended |
Jun. 30, 2023 | |
Class A Ordinary Shares Subject to Possible Redemption | |
Class A Ordinary Shares Subject to Possible Redemption | Note 7 — Class A Ordinary Shares Subject to Possible Redemption The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each ordinary share. As of June 30, 2023 and December 31, 2022, there were 2,811,744 and 29,550,000 shares of Class A ordinary shares outstanding, of which 2,011,744 and 28,750,000 shares were subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets, respectively. The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets is reconciled on the following table: Gross Proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (10,350,000) Class A ordinary shares issuance costs (15,806,778) Plus: Accretion of carrying value to redemption value 26,156,778 Class A ordinary shares subject to possible redemption at December 31, 2021 287,500,000 Increase in Class A ordinary shares subject to possible redemption 3,925,100 Class A ordinary shares subject to possible redemption at December 31, 2022 291,425,100 Less: Redemption of Class A ordinary shares subject to possible redemption (271,939,156) Plus: Increase in Class A ordinary shares subject to possible redemption 1,406,202 Class A ordinary shares subject to possible redemption at March 31, 2023 20,892,146 Plus: Increase in Class A ordinary shares subject to possible redemption 179,734 Class A ordinary shares subject to possible redemption at June 30, 2023 $ 21,071,880 |
Shareholders' Deficit
Shareholders' Deficit | 6 Months Ended |
Jun. 30, 2023 | |
Shareholders' Deficit | |
Shareholders' Deficit | Note 8 — Shareholders’ Deficit Preference Shares Class A Ordinary Shares Class B Ordinary Shares Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon the consummation of the Initial Public Offering (excluding the Private Placement Shares underlying the Private Placement Units), plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination (net of any redemptions of Class A ordinary shares by public shareholders), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any private placement units issued to the Sponsor, members of the management team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Measurements | |
Fair Value Measurements | Note 9 — Fair Value Measurements The following table presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. June 30, 2023 Quoted Prices Significant Other Significant Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Liabilities: Derivative warrant liabilities - Public Warrants $ — $ 287,500 $ — Derivative warrant liabilities - Private Placement Warrants $ — $ 8,000 $ — December 31, 2022 Quoted Prices Significant Other Significant Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account - US Treasury securities $ 291,525,100 $ — $ — Liabilities: Derivative warrant liabilities - Public Warrants $ — $ 191,667 $ — Derivative warrant liabilities - Private Placement Warrants $ — $ 5,333 $ — Working capital loan - related party $ — $ 100,800 $ — Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in March 2021 when the Public Warrants were separately listed and traded. The estimated fair value of the Private Placement Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement at the same time as Public Warrants, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants. The estimated fair value of Public Warrants was transferred from a Level 1 measurement to a Level 2 measurement due to lack of trading activity as of June 30, 2022. The Public Warrants were still held at Level 2 as of June 30, 2023. There were no other transfers to/from Levels 1, 2, and 3 during the period ended June 30, 2023 and December 31, 2022. Level 1 instruments include investments in money market funds that invest solely in U.S. Treasury securities. The Company uses quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Level 2 instruments include Private Placement Warrants, Public Warrants and Working Capital Loan – related party. The Company uses the same quoted market prices from dealers or brokers, and other similar sources as Public Warrants to determine the fair value of its investments. There were no Level 3 measurement inputs used at June 30, 2023 and December 31, 2022. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2023 | |
Subsequent Events | |
Subsequent Events | Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date of the unaudited condensed financial statements were issued. Based upon this review, other than described below the Company determined that there have been no other events that have occurred that would require adjustments to the disclosures in the unaudited condensed financial statements. Agreement and Plan of Merger On July 21, 2023, the Company (including the successor after the Domestication (as defined below), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with BLUA Merger Sub LLC, a Texas limited liability company and wholly-owned subsidiary of the Company (“Merger Sub”), and Spinal Stabilization Technologies, LLC, a Texas limited liability company (“SST”). Pursuant to the Merger Agreement, (i) the Company will domesticate from a Cayman Islands exempted company to a Delaware corporation (the “Domestication”) and (ii) on the Closing Date, following the Domestication, Merger Sub will merge with and into SST (the “Merger” and together with the Domestication and the other transactions contemplated by the Merger Agreement, the “Business Combination”) with SST continuing as the surviving entity of the Merger and a subsidiary of the Company (the “Surviving Company”). The Company following the Business Combination is also referred to as “Surviving Pubco.” Following the consummation of the Business Combination, the combined company will be organized in an “Up-C” structure. The combined company’s business will continue to operate through the Surviving Company and its subsidiaries and the Surviving Pubco’s sole direct asset will be the equity interests of the Surviving Company held by it. The Domestication Prior to the Closing (as defined below), upon the terms and subject to the conditions of the Merger Agreement, the Company will domesticate as a Delaware corporation in accordance with the Delaware General Corporation Law and the Cayman Islands Companies Law (the “Domestication”). In connection with the Domestication, each issued and outstanding Class A ordinary share and Class B ordinary share of the Company will convert into one share of Class A common stock of Surviving Pubco, and each issued and outstanding warrant to purchase Class A ordinary shares of the Company will be exercisable by its terms to purchase an equal number of shares of Class A common stock of Surviving Pubco. Merger Consideration At the effective time of the Merger (the “Effective Time”), by virtue of the Merger and without any action on the part of the Company, SST or any holder of SST membership units immediately prior to the Effective Time (the “Holders”), each SST membership unit that is issued and outstanding immediately prior to the Effective Time shall automatically be converted into and become the right to receive the portion of the shares of Surviving Company Class A Membership Units and Surviving Pubco Class V Common Stock representing, in the aggregate, the Merger Consideration (with each Holder receiving a number of Surviving Company Class A Membership Units and a corresponding number of Surviving PubCo Class V Common Stock equal to the quotient of (a) the amount of cash that the Holder would have received had SST sold all of its assets and made a final liquidating distribution of cash to the Holders in an amount equal to $240,000,000 in accordance with Section 5.4 of SST’s operating agreement, divided by (b) $10.00), in each case, as more particularly set forth on an allocation statement to be delivered by SST to the Company in connection with the consummation of the transactions contemplated by the Merger Agreement (the “Closing”). For purposes of the Merger Agreement, the “Merger Consideration” means a number of Surviving Company Class A Membership Units equal to the quotient determined by dividing $240,000,000 by $10.00 and an equal number of shares of Surviving Pubco Class V Common Stock. For additional information, refer to BlueRiver’s Current Report on Form 8-K, as filed with the SEC on July 24, 2023. Non-Redemption Agreement On July 25, 2023, the Company and the Sponsor, entered into a non-redemption agreement (“Non-Redemption Agreement”) with one or more unaffiliated third party or parties in exchange for such third party or third parties agreeing not to redeem an aggregate of 200,000 shares of the Company sold in its initial public offering (“Non-Redeemed Shares”) at the special meeting called by the Company (the “Second Special Meeting”) to approve an extension of time for the Company to consummate an initial business combination (the “Second Extension Proposal”) from August 2, 2023 to February 2, 2024 (the “Second Extension”). In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to such third party or third parties an aggregate of 40,000 shares of the Company held by the Sponsor immediately following consummation of an initial business combination if they continue to hold such Non-Redeemed Shares through the Second Special Meeting. The Non-Redemption Agreements are not expected to increase the likelihood that the Second Extension Proposal is approved by Company shareholders but will increase the amount of funds that remain in the Company’s trust account following the Second Special Meeting. Second Special Meeting On August 2, 2023, the Company held the Second Special Meeting at which the shareholders voted to extend the time the Company has to consummate an initial business combination from August 2, 2023 to February 2, 2024. |
Basis of Presentation and Sum_2
Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2023 | |
Basis of Presentation and Summary of Significant Accounting Policies | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X and pursuant to the rules and regulations of the SEC. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they are not required for interim financial statements under U.S. GAAP and the rules of the SEC. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the three and six months ended June 30, 2023, and since inception are not necessarily indicative of the results that may be expected through December 31, 2023, or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on March 31, 2023. |
Emerging Growth Company | Emerging Growth Company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of unaudited condensed financial statements in conformity with U. S GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022. |
Cash and Investments Held in Trust Account | Cash and Investments Held in Trust Account The Company classifies its U.S. Treasury and equivalent securities as held to maturity in accordance with FASB Accounting Standard Codification (“ASC”) Topic 320, “Investments – Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts. With respect to the regulation of special purpose acquisition companies (“SPACs”) like the Company, on March 30, 2022, the SEC issued proposed rules relating to, among other items, the circumstances in which SPACs could become subject to regulation under the Investment Company Act. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, in May 2023 the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account until the earlier of consummation of a Business Combination and liquidation of the Company. This may reduce the amount of interest earned by the funds in the Trust Account. As of June 30, 2023, the funds in the Trust Account are held solely in an interest-bearing demand deposit account. At June 30, 2023, substantially all of the assets held in the Trust Account were held in cash. At December 31, 2022, substantially all of the assets held in the Trust Account were held in money market funds which invest primarily in U.S. Treasury securities. The money market funds are presented at fair value within the accompanying condensed balance sheets, and fair value of the investments in the Trust Account is equal to the amortized cost basis of the money market funds. |
Concentration of Credit Risk | Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year that exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets due to their short-term nature, except for derivative warrant liabilities (see Note 9). |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
Derivative Warrant Liabilities | Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Subtopic 815-15 “Derivatives and Hedging — Embedded Derivatives” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants (as defined in Note 4) (collectively, the “warrants”) are recognized as derivative liabilities in accordance with ASC Subtopic 815-40 “Derivatives and Hedging - Contracts in Entity’s Own Equity” (“ASC 815-40”). Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the Public Warrants and the fair value of the Private Placement Warrants has been estimated using a binomial lattice model in a risk-neutral framework. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. The fair value of the Warrants as of June 30, 2023 and December 31, 2022 is based on observable listed prices for such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. |
Convertible Instruments | Convertible Instruments The Company accounted for the Working Capital Loans, as described in Note 4, analyzing the conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments. The Company reviews the terms of convertible debt issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense. It was determined that the conversion option was de minimis, as such the Company has recorded the Working Capital Loans at par value. |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A ordinary shares are charged against their carrying value upon the completion of the Initial Public Offering. For the year ended December 31, 2021, of the total offering costs of the Initial Public Offering, approximately $590,000 is included in offering cost - derivative warrant liabilities in the unaudited condensed statements of operations and approximately $15.8 million is allocated as a reduction to the initial carrying value of the redeemable Class A ordinary shares. The Company will keep deferred underwriting commissions classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. |
Class A Ordinary Shares Subject to Possible Redemption | Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. As part of the Private Placement, the Company issued 800,000 shares of Class A ordinary shares to the Sponsor (“Private Placement Shares”). These Private Placement Shares will not be transferable, assignable or salable until 30 days after the completion of the initial business combination, and as such are considered non-redeemable and presented as permanent equity in the Company’s condensed balance sheets. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2023 and December 31, 2022, 2,011,744 and 28,750,000 Class A ordinary shares subject to possible redemption, respectively, are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A ordinary shares resulted in charges against additional paid-in capital and accumulated deficit. |
Income Taxes | Income Taxes The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. |
Net (Loss) Income per Ordinary Share | Net (Loss) Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of ordinary shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. This presentation assumes a business combination as the most likely outcome. Net (loss) income per ordinary share is calculated by dividing the net (loss) income by the weighted average ordinary shares outstanding for the respective period. The calculation of diluted net (loss) income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 9,850,000 Class A ordinary shares in the calculation of diluted (loss) income per ordinary share, because their exercise is contingent upon future events. As a result, diluted net (loss) income per ordinary share is the same as basic net (loss) income per share ordinary for the three and six months ended June 30, 2023 and 2022. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. The Company has considered the effect of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares. The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per ordinary share for each class of ordinary shares: For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net (loss) income - Basic and diluted $ (62,993) $ (161,024) $ 985,943 $ 239,813 $ (616,481) $ (622,363) $ 3,456,857 $ 840,818 Denominator: Basic and diluted weighted average ordinary shares outstanding 2,811,745 7,187,500 29,550,000 7,187,500 7,119,575 7,187,500 29,550,000 7,187,500 Basic and diluted net (loss) income per ordinary share $ (0.02) $ (0.02) $ 0.03 $ 0.03 $ (0.09) $ (0.09) $ 0.12 $ 0.12 |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the unaudited condensed financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. |
Basis of Presentation and Sum_3
Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Basis of Presentation and Summary of Significant Accounting Policies | |
Schedule of reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per ordinary share | For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net (loss) income - Basic and diluted $ (62,993) $ (161,024) $ 985,943 $ 239,813 $ (616,481) $ (622,363) $ 3,456,857 $ 840,818 Denominator: Basic and diluted weighted average ordinary shares outstanding 2,811,745 7,187,500 29,550,000 7,187,500 7,119,575 7,187,500 29,550,000 7,187,500 Basic and diluted net (loss) income per ordinary share $ (0.02) $ (0.02) $ 0.03 $ 0.03 $ (0.09) $ (0.09) $ 0.12 $ 0.12 |
Related Party Transactions (Tab
Related Party Transactions (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Related Party Transactions | |
Schedule of fair value of the founders shares | January 25, 2023 Share price at grant date $ 10.03 Risk-free interest rate 4.67 % Remaining life of SPAC (assuming the Extended Date) 0.52 Value in no De-SPAC scenario $ 10.39 Probability of transaction 50 % Discount rate 5 % |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies | |
Schedule of fair value of the founders shares | January 25, 2023 Share price at grant date $ 10.03 Risk-free interest rate 4.67 % Remaining life of SPAC (assuming the Extended Date) 0.52 Value in no De-SPAC scenario $ 10.39 Probability of transaction 50 % Discount rate 5 % |
Consulting Agreement | |
Commitments and Contingencies | |
Schedule of fair value of the founders shares | March 21, 2023 Share price at grant date $ 10.15 Risk-free interest rate 4.62 % Remaining life of SPAC (assuming the Extended Date) 0.37 Share price in no De-SPAC scenario $ 10.39 Probability of transaction 50 % Discount rate 5 % |
Class A Ordinary Shares Subje_2
Class A Ordinary Shares Subject to Possible Redemption (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Class A Ordinary Shares Subject to Possible Redemption | |
Schedule of reconciliation of Class A common stock reflected on the balance sheet | Gross Proceeds $ 287,500,000 Less: Proceeds allocated to Public Warrants (10,350,000) Class A ordinary shares issuance costs (15,806,778) Plus: Accretion of carrying value to redemption value 26,156,778 Class A ordinary shares subject to possible redemption at December 31, 2021 287,500,000 Increase in Class A ordinary shares subject to possible redemption 3,925,100 Class A ordinary shares subject to possible redemption at December 31, 2022 291,425,100 Less: Redemption of Class A ordinary shares subject to possible redemption (271,939,156) Plus: Increase in Class A ordinary shares subject to possible redemption 1,406,202 Class A ordinary shares subject to possible redemption at March 31, 2023 20,892,146 Plus: Increase in Class A ordinary shares subject to possible redemption 179,734 Class A ordinary shares subject to possible redemption at June 30, 2023 $ 21,071,880 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Measurements | |
Schedule of company's financial assets and liabilities that are measured at fair value | June 30, 2023 Quoted Prices Significant Other Significant Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Liabilities: Derivative warrant liabilities - Public Warrants $ — $ 287,500 $ — Derivative warrant liabilities - Private Placement Warrants $ — $ 8,000 $ — December 31, 2022 Quoted Prices Significant Other Significant Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account - US Treasury securities $ 291,525,100 $ — $ — Liabilities: Derivative warrant liabilities - Public Warrants $ — $ 191,667 $ — Derivative warrant liabilities - Private Placement Warrants $ — $ 5,333 $ — Working capital loan - related party $ — $ 100,800 $ — |
Description of Organization, _2
Description of Organization, Business Operations and Liquidity (Details) | 1 Months Ended | 6 Months Ended | ||||||
Jul. 25, 2023 shares | Jan. 27, 2023 USD ($) shares | Jan. 25, 2023 shares | Feb. 02, 2021 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) | Jun. 30, 2023 USD ($) item $ / shares | Jun. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | |
Description of Organization, Business Operations and Liquidity | ||||||||
Condition for future business combination number of businesses minimum | item | 1 | |||||||
Offering costs | $ 75,000 | |||||||
Deferred underwriting commissions | $ 10,062,500 | $ 10,062,500 | ||||||
Minimum market value of acquire to net asset held in Trust Account (as a percent) | 80% | |||||||
Minimum post-business combination ownership (as a percent) | 50% | |||||||
Redemption value of public shares (in dollars per share) | $ / shares | $ 10 | |||||||
Minimum net tangible asset upon consummation of business combination | $ 5,000,001 | |||||||
Minimum percentage of shares requiring prior consent by entity | 15% | |||||||
Public shares to be redeemed if business combination is not completed (as a percent) | 100% | |||||||
Threshold period from closing of public offering the company is obligated to complete business combination | 36 months | |||||||
Extension term the company is obligated to complete business combination | 6 months | |||||||
Threshold business days for redemption of shares of trust account | 10 days | |||||||
Maximum net interest to pay dissolution expenses | $ 100,000 | |||||||
Non-redemption agreement | ||||||||
Description of Organization, Business Operations and Liquidity | ||||||||
Aggregate shares redeem | shares | 200,000 | |||||||
Number of shares issued | shares | 50,000 | |||||||
Aggregate public shares exercised | shares | 26,738,255 | |||||||
Cash held in the Trust Account | $ 271,939,156 | |||||||
Non-redemption agreement | Subsequent Event | ||||||||
Description of Organization, Business Operations and Liquidity | ||||||||
Aggregate shares redeem | shares | 200,000 | |||||||
Number of shares issued | shares | 50,000 | |||||||
Initial Public Offering | ||||||||
Description of Organization, Business Operations and Liquidity | ||||||||
Number of units issued | shares | 28,750,000 | |||||||
Purchase price, per unit (in dollars per unit) | $ / shares | $ 10 | |||||||
Gross proceeds received from initial public offering | $ 287,500,000 | |||||||
Offering costs | 16,400,000 | $ 590,000 | ||||||
Deferred underwriting commissions | 10,100,000 | |||||||
Investment of cash into Trust Account | $ 287,500,000 | |||||||
Private Placement | ||||||||
Description of Organization, Business Operations and Liquidity | ||||||||
Number of warrants to purchase shares issued | shares | 800,000 | |||||||
Price of warrant (in dollars per unit) | $ / shares | $ 10 | |||||||
Proceeds received from private placement | $ 8,000,000 | |||||||
Over-allotment option | ||||||||
Description of Organization, Business Operations and Liquidity | ||||||||
Number of units issued | shares | 3,750,000 | |||||||
Purchase price, per unit (in dollars per unit) | $ / shares | $ 10 | |||||||
Public Share | ||||||||
Description of Organization, Business Operations and Liquidity | ||||||||
Purchase price, per unit (in dollars per unit) | $ / shares | $ 10 |
Description of Organization, _3
Description of Organization, Business Operations and Liquidity - Liquidity (Details) - USD ($) | 6 Months Ended | ||||||
Jun. 30, 2023 | Apr. 25, 2023 | Mar. 24, 2023 | Feb. 27, 2023 | Dec. 31, 2022 | Nov. 17, 2022 | Nov. 09, 2022 | |
Description of Organization, Business Operations and Liquidity | |||||||
Cash in operating bank account | $ 106,000 | ||||||
Working capital deficit | 2,300,000 | ||||||
Proceeds received from note payable to related party | 545,000 | ||||||
Promissory note agreement | |||||||
Description of Organization, Business Operations and Liquidity | |||||||
Amount of borrowing ability | 545,000 | $ 100,000 | |||||
Notes Payable to Sponsor | |||||||
Description of Organization, Business Operations and Liquidity | |||||||
Loan amount from Sponsor outstanding | 79,000 | ||||||
Working Capital Loans | |||||||
Description of Organization, Business Operations and Liquidity | |||||||
Proceeds received from note payable to related party | 25,000 | ||||||
Loan amount from Sponsor outstanding | $ 645,000 | $ 100,000 | |||||
Sponsor Promissory Note Agreement | |||||||
Description of Organization, Business Operations and Liquidity | |||||||
Amount of borrowing ability | $ 25,000 | $ 20,000 | $ 75,000 | $ 1,500,000 |
Basis of Presentation and Sum_4
Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($) | 1 Months Ended | 6 Months Ended | 12 Months Ended | |||
Feb. 02, 2021 | Dec. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | |
Basis of Presentation and Summary of Significant Accounting Policies | ||||||
Cash equivalents | $ 0 | $ 0 | ||||
Offering costs | $ 75,000 | |||||
Class A ordinary shares subject to possible redemption, shares outstanding | 2,011,744 | |||||
Unrecognized tax benefits | $ 0 | $ 0 | ||||
Anti-dilutive securities attributable to warrants excluded from calculation of diluted income per share (in shares) | 9,850,000 | |||||
Initial Public Offering | ||||||
Basis of Presentation and Summary of Significant Accounting Policies | ||||||
Offering costs | $ 16,400,000 | $ 590,000 | ||||
Offering costs included in shareholders' equity | $ 15,800,000 | |||||
Class A ordinary shares | Private Placement | ||||||
Basis of Presentation and Summary of Significant Accounting Policies | ||||||
Number of shares issued | 800,000 | |||||
Class A ordinary shares subject to possible redemption | ||||||
Basis of Presentation and Summary of Significant Accounting Policies | ||||||
Class A ordinary shares subject to possible redemption, shares outstanding | 2,011,744 | 28,750,000 |
Basis of Presentation and Sum_5
Basis of Presentation and Summary of Significant Accounting Policies - Reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per ordinary share (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Class A | ||||
Numerator: | ||||
Allocation of net (loss) income - Basic | $ (62,993) | $ 985,943 | $ (616,481) | $ 3,456,857 |
Allocation of net (loss) income - Diluted | $ (62,993) | $ 985,943 | $ (616,481) | $ 3,456,857 |
Denominator: | ||||
Basic weighted average ordinary shares outstanding | 2,811,745 | 29,550,000 | 7,119,575 | 29,550,000 |
Diluted weighted average ordinary shares outstanding | 2,811,745 | 29,550,000 | 7,119,575 | 29,550,000 |
Basic net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
Diluted net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
Class B | ||||
Numerator: | ||||
Allocation of net (loss) income - Basic | $ (161,024) | $ 239,813 | $ (622,363) | $ 840,818 |
Allocation of net (loss) income - Diluted | $ (161,024) | $ 239,813 | $ (622,363) | $ 840,818 |
Denominator: | ||||
Basic weighted average ordinary shares outstanding | 7,187,500 | 7,187,500 | 7,187,500 | 7,187,500 |
Diluted weighted average ordinary shares outstanding | 7,187,500 | 7,187,500 | 7,187,500 | 7,187,500 |
Basic net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
Diluted net (loss) income per ordinary share | $ (0.02) | $ 0.03 | $ (0.09) | $ 0.12 |
Initial Public Offering (Detail
Initial Public Offering (Details) - USD ($) | 1 Months Ended | 6 Months Ended | |||
Feb. 02, 2021 | Dec. 31, 2021 | Jun. 30, 2022 | Jun. 30, 2023 | Dec. 31, 2022 | |
Initial Public Offering | |||||
Offering costs | $ 75,000 | ||||
Deferred underwriting commissions | $ 10,062,500 | $ 10,062,500 | |||
Initial Public Offering | |||||
Initial Public Offering | |||||
Number of units issued | 28,750,000 | ||||
Price per share | $ 10 | ||||
Gross proceeds received from initial public offering | $ 287,500,000 | ||||
Offering costs | 16,400,000 | $ 590,000 | |||
Deferred underwriting commissions | $ 10,100,000 | ||||
Initial Public Offering | Public Warrants | |||||
Initial Public Offering | |||||
Number of shares in a unit | 1 | ||||
Number of warrants in a unit | 0.33 | ||||
Number of shares issuable per warrant | 1 | ||||
Exercise price of warrants | $ 11.50 | ||||
Over-allotment option | |||||
Initial Public Offering | |||||
Number of units issued | 3,750,000 |
Related Party Transactions - Fo
Related Party Transactions - Founder Shares (Details) | 6 Months Ended | ||
Feb. 02, 2021 USD ($) $ / shares shares | Oct. 30, 2020 USD ($) $ / shares shares | Jun. 30, 2023 D $ / shares shares | |
Related Party Transactions | |||
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination | 1 year | ||
Private Placement | |||
Related Party Transactions | |||
Number of shares per warrant | shares | 1 | ||
Number of warrants to purchase shares issued | shares | 800,000 | ||
Proceeds received from private placement | $ | $ 8,000,000 | ||
Exercise price of warrants | $ / shares | $ 11.50 | ||
Price of warrants (in dollars per share) | $ / shares | $ 10 | $ 10 | |
Private Placement | Class B ordinary shares | |||
Related Party Transactions | |||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D | 30 | ||
Founder Shares | Sponsor | |||
Related Party Transactions | |||
Number of shares for which forfeiture condition has expired (in shares) | shares | 937,500 | 937,500 | |
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders | 20% | ||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D | 20 | ||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares | $ 12 | ||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D | 30 | ||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 150 days | ||
Founder Shares | Sponsor | Class B ordinary shares | |||
Related Party Transactions | |||
Aggregate purchase price | $ | $ 25,000 | ||
Number of shares issued | shares | 7,187,500 | ||
Shares subject to forfeit par value | $ / shares | 0.0001 |
Related Party Transactions - Fa
Related Party Transactions - Fair value of the founder shares (Details) | Jan. 25, 2023 Y item $ / shares |
Share price at grant date | |
Related Party Transactions | |
Fair value of the founders shares | $ / shares | 10.03 |
Risk-free interest rate | |
Related Party Transactions | |
Fair value of the founders shares | 0.0467 |
Remaining life of SPAC (assuming the Extended Date) | |
Related Party Transactions | |
Fair value of the founders shares | Y | 0.52 |
Value in no De-SPAC scenario | |
Related Party Transactions | |
Fair value of the founders shares | item | 0.1039 |
Probability of transaction | |
Related Party Transactions | |
Fair value of the founders shares | 0.50 |
Discount rate | |
Related Party Transactions | |
Fair value of the founders shares | 0.05 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||
Jan. 25, 2023 | Feb. 05, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | May 09, 2023 | Jan. 31, 2023 | Nov. 17, 2022 | Nov. 09, 2022 | Oct. 23, 2020 | |
Related Party Transactions | ||||||||||||
Proceeds from issuance of working capital loan to related party | $ 545,000 | |||||||||||
Administrative Support Agreement | ||||||||||||
Related Party Transactions | ||||||||||||
Amount agreed to pay to sponsor under administrative support agreement | 50,000 | |||||||||||
Expenses incurred and paid | $ 150,000 | 300,000 | $ 600,000 | |||||||||
Administrative Support Agreement | Accrued liabilities | ||||||||||||
Related Party Transactions | ||||||||||||
Expenses incurred and paid | $ 150,000 | 785,000 | $ 300,000 | |||||||||
Administrative Support Agreement | Sponsor | ||||||||||||
Related Party Transactions | ||||||||||||
Outstanding balance of related party note | 0 | 0 | 0 | |||||||||
Expenses incurred and paid | 1,141 | $ 16,121 | 1,141 | $ 16,121 | ||||||||
Working Capital Loans | ||||||||||||
Related Party Transactions | ||||||||||||
Maximum loans convertible into warrants | $ 1,500,000 | $ 1,500,000 | ||||||||||
Price of warrant (in dollars per unit) | $ 10 | $ 10 | ||||||||||
Outstanding balance of related party note | $ 645,000 | $ 645,000 | $ 100,000 | |||||||||
Sponsor | ||||||||||||
Related Party Transactions | ||||||||||||
Maximum borrowing capacity of related party promissory note | $ 300,000 | |||||||||||
Proceeds from issuance of working capital loan to related party | $ 79,000 | |||||||||||
Sponsor Promissory Note Agreement | ||||||||||||
Related Party Transactions | ||||||||||||
Maximum borrowing capacity of related party promissory note | $ 1,500,000 | |||||||||||
Amount drew down | $ 175,000 | $ 250,000 | $ 100,000 | |||||||||
Non-redemption agreement | ||||||||||||
Related Party Transactions | ||||||||||||
Number of holders of shares who accepted non-redemption agreement | 1,932,000 | |||||||||||
Committed ownership interest | 9.90% | |||||||||||
Number of shares issued | 50,000 | |||||||||||
Number of founder share under agreement | 483,000 | |||||||||||
Aggregate fair value of founder shares | $ 2,333,639 | |||||||||||
Per Share fair value of founder shares | $ 4.83 |
Commitments and Contingencies_2
Commitments and Contingencies (Details) | 6 Months Ended | ||
Mar. 13, 2023 USD ($) shares | Feb. 02, 2021 USD ($) $ / shares shares | Jun. 30, 2023 USD ($) item $ / shares shares | |
Commitments and Contingencies | |||
Maximum number of demands for registration of securities | item | 3 | ||
Lock up period for registration statement after Business Combination | 30 days | ||
Consulting Agreement | |||
Commitments and Contingencies | |||
Fees incurred as consideration for service | $ 100,000 | ||
Fees payable upon signing of the Engagement Letter | $ 100,000 | ||
Stock-based compensation expenses | $ 1,701,444 | ||
Founder shares issued as consideration for service | shares | 350,000 | 350,000 | |
Aggregate fair value of founder shares | shares | 1,701,444 | ||
Per Share fair value of founder shares | $ / shares | $ 4.86 | ||
Number of founder share under agreement | shares | 350,000 | 350,000 | |
Over-allotment option | |||
Commitments and Contingencies | |||
Underwriting option period | 45 days | ||
Ordinary shares, shares authorized | shares | 3,750,000 | ||
Underwriting cash discount per unit | $ / shares | $ 0.20 | ||
Underwriter cash discount | $ 5,800,000 | ||
Aggregate underwriter cash discount | 0.35 | ||
Aggregate deferred underwriting fee payable | $ 10,100,000 |
Commitments and Contingencies -
Commitments and Contingencies - Consulting Agreement (Details) - Consulting Agreement | Mar. 21, 2023 $ / shares Y |
Share price at grant date | |
Commitments And Contingencies [Line Items] | |
Fair value of the founders shares | 10.15 |
Risk-free interest rate | |
Commitments And Contingencies [Line Items] | |
Fair value of the founders shares | 0.0462 |
Remaining life of SPAC (assuming the Extended Date) | |
Commitments And Contingencies [Line Items] | |
Fair value of the founders shares | Y | 0.37 |
Share price in no De-SPAC scenario | |
Commitments And Contingencies [Line Items] | |
Fair value of the founders shares | 10.39 |
Probability of transaction | |
Commitments And Contingencies [Line Items] | |
Fair value of the founders shares | 0.50 |
Discount rate | |
Commitments And Contingencies [Line Items] | |
Fair value of the founders shares | 0.05 |
Derivative Warrant Liabilities
Derivative Warrant Liabilities (Details) | 6 Months Ended | |
Jun. 30, 2023 D $ / shares shares | Dec. 31, 2022 shares | |
Derivative Warrant Liabilities | ||
Maximum threshold period for registration statement to become effective after business combination | 60 days | |
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination | 1 year | |
Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 | ||
Derivative Warrant Liabilities | ||
Threshold consecutive trading days for redemption of public warrants | D | 30 | |
Warrants | ||
Derivative Warrant Liabilities | ||
Exercise price of warrant | $ 11.50 | |
Public Warrants expiration term | 5 years | |
Threshold issue price per share | $ 9.20 | |
Percentage of gross proceeds on total equity proceeds | 60% | |
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent) | 115% | |
Adjustment of redemption price of stock based on market value (as a percent) | 100 | |
Adjustment of redemption price of stock based on newly issued price 2 (as a percent) | 180 | |
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination | 30 days | |
Number of trading days on which fair market value of shares is reported | D | 10 | |
Threshold trading days determining volume weighted average price | 20 days | |
Warrants | Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 | ||
Derivative Warrant Liabilities | ||
Stock price trigger for redemption of public warrants (in dollars per share) | $ 18 | |
Warrants | Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 | ||
Derivative Warrant Liabilities | ||
Stock price trigger for redemption of public warrants (in dollars per share) | 10 | |
Fair market value per share | $ 0.361 | |
Private Placement Warrants | ||
Derivative Warrant Liabilities | ||
Warrants outstanding | shares | 266,667 | |
Public Warrants | ||
Derivative Warrant Liabilities | ||
Warrants outstanding | shares | 9,583,333 | |
Threshold number of business days before sending notice of redemption to warrant holders | 30 days | |
Public Warrants exercisable term from the closing of the initial public offering | 12 months | |
Threshold period for filling registration statement after business combination | 20 days | |
Public Warrants | Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 | ||
Derivative Warrant Liabilities | ||
Warrant redemption condition minimum share price | $ 18 | |
Redemption price per public warrant (in dollars per share) | $ 0.01 | |
Redemption period | 30 days | |
Threshold trading days for redemption of public warrants | D | 20 | |
Threshold consecutive trading days for redemption of public warrants | D | 30 | |
Public Warrants | Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 | ||
Derivative Warrant Liabilities | ||
Warrant redemption condition minimum share price | $ 10 | |
Redemption price per public warrant (in dollars per share) | 0.10 | |
Warrant redemption condition minimum share price scenario two | $ 18 |
Class A Ordinary Shares Subje_3
Class A Ordinary Shares Subject to Possible Redemption - Additional information (Details) | Jun. 30, 2023 Vote $ / shares shares | Dec. 31, 2022 $ / shares shares |
Class A Ordinary Shares Subject to Possible Redemption | ||
Number of votes per share | Vote | 1 | |
Ordinary shares, outstanding, subject to possible redemption | 2,011,744 | |
Class A ordinary shares | ||
Class A Ordinary Shares Subject to Possible Redemption | ||
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, par value (per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares outstanding | 2,811,744 | 29,550,000 |
Class A ordinary shares subject to possible redemption | ||
Class A Ordinary Shares Subject to Possible Redemption | ||
Number of votes per share | Vote | 1 | |
Ordinary shares, outstanding, subject to possible redemption | 2,011,744 | 28,750,000 |
Class A Ordinary Shares Subje_4
Class A Ordinary Shares Subject to Possible Redemption (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Class A Ordinary Shares Subject to Possible Redemption | ||||
Gross Proceeds | $ 287,500,000 | |||
Proceeds allocated to Public Warrants | (10,350,000) | |||
Class A ordinary shares issuance costs | (15,806,778) | |||
Class A ordinary shares subject to possible redemption | $ 21,071,880 | $ 20,892,146 | $ 291,425,100 | 287,500,000 |
Redemption of Class A ordinary shares subject to possible redemption | (271,939,156) | |||
Increase in Class A ordinary shares subject to possible redemption | $ 179,734 | $ 1,406,202 | $ 3,925,100 | $ 26,156,778 |
Shareholders' Deficit - Prefere
Shareholders' Deficit - Preference Shares (Details) - shares | Jun. 30, 2023 | Dec. 31, 2022 |
Shareholders' Deficit | ||
preference shares, shares authorized | 1,000,000 | 1,000,000 |
preference shares, shares issued | 0 | 0 |
preference shares, shares outstanding | 0 | 0 |
Shareholders' Deficit - Ordinar
Shareholders' Deficit - Ordinary Shares (Details) | 6 Months Ended | |
Jun. 30, 2023 Vote $ / shares shares | Dec. 31, 2022 $ / shares shares | |
Shareholders' Deficit | ||
Ordinary shares, votes per share | Vote | 1 | |
Class A ordinary shares subject to possible redemption, shares outstanding | 2,011,744 | |
Class A ordinary shares | ||
Shareholders' Deficit | ||
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares outstanding | 2,811,744 | 29,550,000 |
Class A ordinary shares subject to possible redemption | ||
Shareholders' Deficit | ||
Ordinary shares, votes per share | Vote | 1 | |
Class A ordinary shares subject to possible redemption, shares outstanding | 2,011,744 | 28,750,000 |
Class B ordinary shares | ||
Shareholders' Deficit | ||
Ordinary shares, shares authorized | 20,000,000 | 20,000,000 |
Ordinary shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Ordinary shares, shares issued | 7,187,500 | 7,187,500 |
Ordinary shares, shares outstanding | 7,187,500 | 7,187,500 |
Ratio to be applied to the stock in the conversion | 20 | |
Conversion ratio | 1 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Liabilities: | ||
Derivative warrant liabilities | $ 295,500 | $ 197,000 |
Working capital loan - related party | 645,000 | 100,800 |
Asset transfer, into level 3 | 0 | 0 |
Asset transfer, out of level 3 | 0 | 0 |
Liabilities transfer, into level 3 | 0 | 0 |
Liabilities transfer, out of level 3 | 0 | 0 |
Level 1 | U.S. Treasury Securities | Recurring | ||
Assets: | ||
Investments held in Trust Account | 291,525,100 | |
Level 2 | Recurring | ||
Liabilities: | ||
Working capital loan - related party | 100,800 | |
Level 2 | Recurring | Public Warrants | ||
Liabilities: | ||
Derivative warrant liabilities | 287,500 | 191,667 |
Level 2 | Recurring | Private Placement Warrants | ||
Liabilities: | ||
Derivative warrant liabilities | $ 8,000 | $ 5,333 |
Subsequent Events (Details)
Subsequent Events (Details) - Subsequent Event - USD ($) | Jul. 25, 2023 | Jul. 21, 2023 |
Unaffiliated third parties | Non-redemption agreement | ||
Subsequent Events | ||
Non-Redeemed Shares | 200,000 | |
Sponsor | Unaffiliated third parties | Non-redemption agreement | ||
Subsequent Events | ||
Aggregate number of shares agreed to transfer immediately following consummation of an initial business combination | 40,000 | |
Surviving Pubco | ||
Subsequent Events | ||
Number of shares converted in to Class A Common stock | 1 | |
Final liquidating distribution of cash to the holders if all assets had sold | $ 240,000,000 | |
Price used as denominator for calculating merger consideration | $ 10 |